Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSS icon
Numerous advances in cardiac nuclear imaging led American Society of Nuclear Cardiology (ASNC) President-elect Panithaya Chareonthaitawee, MD, to predict "We are on the edge of a new journey in nuclear cardiology, and the opportunities before us are just as vast as they are exciting and promising."

ASNC president-elect predicts unprecedented innovation in nuclear cardiology

"We are on the edge of a new journey in nuclear cardiology," explained ASNC President-elect Panithaya Chareonthaitawee, MD.

 

cardiologists evaluating the human heart to provide a treatment strategy

Treating AFib with another ablation after PVI provides little value

Care teams regularly targeting AFib symptoms with LVA ablation in addition to PVI may want to reconsider. 

Time running out to comment on higher cardiac CT payments

Imaging experts have said the move could reshape the financial landscape for hospitals offering Cardiac CT services.

robot reviewing heart data

Viz.ai partners with Cleerly in the name of AI-based CCTA evaluations

The new partnership is focused on getting advanced AI algorithms into the hands of cardiologists.

OCT-guided PCI, or optical coherence tomography-guided percutaneous coronary intervention.

OCT-guided PCI boosts outcomes when treating complex lesions

When PCI patients present with complex lesions, optical coherence tomography may provide significant value.

FDA clears new suite of ECG evaluation tools

HeartKey Rhythm was designed to help care teams keep up with the rising amount of ECG data they receive on a regular basis.

The MODULAR ATP study demonstrated a high rate of successful leadless pacemaker implantation with few complications and stable pacing parameters. The system uses the Emblem Subcutaneous Implantable Defibrillator (S-ICD) System and the new Empower Leadless Pacemaker from Boston Scientific.

Completely leadless cardiac rhythm management system impresses

According to new MODULAR ATP data, the leadless system was associated with a high success rate and few complications. Boston Scientific plans on seeking FDA approval in 2025. 

Banner ASC in Sun City, Arizona.

PAD patients fare better when they have a strong support system

PAD patients with a strong social support system were associated with better outcomes in a new analysis published in the Journal of Vascular Surgery.

Displaying 105 - 112 of 1685
Design by Adaptive Theme